The California Institute for Medical Research (CIMR) and Riptide Bioscience, Inc. announce the publication of a research study demonstrating remarkable efficacy for Riptide’s drug candidate RP557 in recurrent vaginal fungal infections. The study, entitled “Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment,” appears in the August 2019 issue of Antimicrobial Agents and Chemotherapy, a publication of the American Society for …
Infectious Disease Research Laboratory, CIMR, publications, calendar year 2018
Phillips, A., Fiorello, C.V., Baden, R.M., Liu J., Burmas, N., Ruvalcaba, C., Monroy, R., Mohr, F.C., Gehring, R., Delplanque, J-P., Clemons, K.V., Stevens, D.A., Tell, L.A. Amphotericin B concentrations in mallard ducks following a single intratracheal dose of liposomal amphotericin B using an atomizer. Med. Mycol. 56:322-331, 2018. Anand, R., Moss, R., Sass, G., Banaei, N., Clemons, K.V., Martinez, M., …